Approval · Notice of Compliance 5594 · 1994
DEMADEX: Notice of Compliance 5594
Issued September 27, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5594
- Date
- September 27, 1994
- Company
- Boehringer Mannheim (Canada) LteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Diuretic, antihypertensive
Products in this notice
Medicinal ingredients
- TORASEMIDE 5 MG per TAB
- TORASEMIDE 10 MG per TAB
- TORASEMIDE 20 MG per TAB
- TORASEMIDE 100 MG per TAB
- TORASEMIDE 10 MG per ML